Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies

Hanneke A. Haijes,Peter M. Hasselt,Judith J. M. Jans,Nanda M. Verhoeven‐Duif
DOI: https://doi.org/10.1002/jimd.12128
IF: 4.7501
2019-07-09
Journal of Inherited Metabolic Disease
Abstract:Despite realizing increased survival rates for propionic acidemia (PA) and methylmalonic acidemia (MMA) patients, the current therapeutic regimen is inadequate for preventing or treating the devastating complications that still can occur. The elucidation of pathophysiology of these complications allows us to evaluate and rethink treatment strategies. In this review we display and discuss potential therapy targets and we give a systematic overview on current, experimental and unexplored treatment strategies in order to provide insight in what we have to offer PA and MMA patients, now and in the future.
genetics & heredity,endocrinology & metabolism,medicine, research & experimental
What problem does this paper attempt to address?